ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs MXN
17.1601
0.00%
Brent Oil
88.165
0.00%
Bitcoin
63,727.65
0.50%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Synlogic Inc (SYBX)

  7. Synlogic Inc (SYBX) Noticias

SYBX Synlogic Inc

1.87
0.01 (0.54%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Synlogic Inc SYBX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.01 0.54% 1.87 15:00:09
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.87 1.84 1.88 1.87 1.86
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
19/3/202406:00GLOBESynlogic Reports Fourth Quarter and Full Year 2023 Financial..
22/2/202415:37EDGAR2Form 8-K - Current report
20/2/202416:05EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
20/2/202415:06EDGAR2Form 8-K - Current report
20/2/202411:15GLOBESynlogic Adopts Limited Duration Stockholders Rights Plan
16/2/202415:54EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/2/202415:44EDGAR2Form SC 13D - General statement of acquisition of beneficial..
14/2/202414:55EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/2/202415:00EDGAR2Form 8-K - Current report
08/2/202415:15GLOBESynlogic Announces Decision to Discontinue Synpheny-3 Study..
02/2/202411:00GLOBESynlogic Announces Publication of Preclinical and Clinical..
04/1/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202406:00GLOBESynlogic Provides Corporate Update and Outlook for 2024
29/12/202315:00EDGAR2Form 8-K - Current report
27/12/202306:00GLOBESynlogic Announces Contract with the Air Force Research Lab
07/12/202306:00GLOBESynlogic Announces Abstract Accepted for Poster Presentation..
17/11/202315:00EDGAR2Form 8-K - Current report
14/11/202318:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202318:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202318:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202306:00GLOBESynlogic Reports Third Quarter 2023 Financial Results and..
09/11/202305:44EDGAR2Form 8-K - Current report
09/11/202305:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:00GLOBESynlogic Achieves Research Milestone and Earns $2.5 Million..
07/11/202305:45EDGAR2Form 8-K - Current report
13/10/202315:17EDGAR2Form SC 13D/A - General statement of acquisition of..
03/10/202315:15GLOBESynlogic Announces Closing of $21.0 Million Underwritten..
02/10/202316:05EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
29/9/202307:53EDGAR2Form 8-K - Current report
29/9/202306:00GLOBESynlogic Announces Pricing of $21.0 Million Underwritten..
28/9/202320:43EDGAR2Form S-1MEF - Registration adding securities to prior Form..
28/9/202315:15EDGAR2Form 8-K - Current report
28/9/202310:15GLOBESynlogic Announces Publication of Synpheny-1 Phase 2 Study..
28/9/202307:39EDGAR2Form S-1/A - General form for registration of securities..
27/9/202311:30GLOBESynlogic Announces Reverse Stock Split
26/9/202320:41EDGAR2Form S-1/A - General form for registration of securities..
22/9/202315:15EDGAR2Form 8-K - Current report
21/9/202306:00GLOBESynlogic to Participate in Chardan’s Genetic Medicines..
19/9/202310:00GLOBESynlogic Announces CEO Aoife Brennan Named to PharmaVoice..
08/9/202315:06EDGAR2Form S-1 - General form for registration of securities under..
01/9/202307:00EDGAR2Form DEF 14A - Other definitive proxy statements
21/8/202316:15EDGAR2Form PRE 14A - Other preliminary proxy statements
16/8/202315:05EDGAR2Form 8-K - Current report
10/8/202306:00GLOBESynlogic Reports Second Quarter 2023 Financial Results and..
10/8/202305:35EDGAR2Form 8-K - Current report
10/8/202305:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/7/202306:00GLOBESynlogic Granted Fast Track Designation from FDA for..
28/6/202306:00GLOBESynlogic Announces International Nonproprietary Name..
27/6/202306:00GLOBESynlogic Announces Participation in SVB Securities..
08/6/202305:45GLOBESynlogic Reminds Stockholders of 2023 Annual General Meeting..

Su Consulta Reciente

NASDAQ
SYBX
Synlogic
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados